1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with enantio-PAF C-16 in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (enantio-PAF C-16) | Trials (enantio-PAF C-16) | Recent Studies (post-2010) (enantio-PAF C-16) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 11 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, Y; Kodama, H; Matsumoto, T; Nakamura, M; Noma, M; Shimizu, T | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and enantio-PAF C-16
| Article | Year |
|---|---|
A radioreceptor binding assay for platelet-activating factor (PAF) using membranes from CHO cells expressing human PAF receptor.
Topics: Animals; CHO Cells; Cricetinae; Cricetulus; Humans; Lipids; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Platelet Activating Factor; Platelet Membrane Glycoproteins; Radioligand Assay; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Recombinant Fusion Proteins; Reproducibility of Results | 1995 |